Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 9 SVRA Savara GAAP EPS of -$0.11 misses by $0.01
May 9 SVRA Savara Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 NBIX How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
May 9 GMED GMED or PEN: Which Is the Better Value Stock Right Now?
May 9 CLDX Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
May 9 NBIX Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
May 9 GMED Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
May 9 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adults
May 9 GMED Surgical robots are ‘gift that will keep on giving,’ ortho firms say
May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
May 9 ICLR ICON releases its ICON Cares 2023 Report
May 9 GMED Three Growth Companies With High Insider Ownership And 36% Earnings Growth
May 8 GMED Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript
May 8 GMED Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
May 8 GMED Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 REGN Regeneron gene therapy improves hearing in two children
May 8 CLDX Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags